focus -WSS

focus

author：focus 2025-09-27 12:22:39 - browse：8454

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Elon Musk announces 'temporary limits' for reading Twitter posts

WSS

As Taiwan prepares for anti

White House launches permanent pandemic office

HIPAA doesn't protect reproductive records from prosecutors

4 dead, 2 in stable condition in Philadelphia shooting: Police

Caitlin Bernard's story shows physicians can't shy from advocacy

Body of missing toddler recovered in Delaware River days after flood: Police

hotspot

focus

hotspot

Psychedelics group wrestles with new pharma identity

Artificial intelligence advances fuel industry trying to preserve loved ones after death

In Memoriam: Notable people who died in 2023

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Trump demands the U.S. pay no more for drugs than other countries … again

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

1 dead, 9 hurt in July 4th fireworks explosion

Supreme Court strikes down use of affirmative action

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

leisure time

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Churchill Downs extends trainer Bob Baffert's ban through 2024

Caitlin Bernard's story shows physicians can't shy from advocacy

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

knowledge

knowledge

focus

focus